Home About

AndroGel

TESTOSTERONE

Manufacturer: ASCEND Therapeutics U.S., LLC

Score: 144.0

Quick Summary

Testosterone topical solution is used for replacement therapy in males with conditions associated with a deficiency or absence of endogenous testosterone. The solution delivers physiologic circulating testosterone that approximates normal concentration ranges seen in healthy men. Key clinical findings indicate the importance of proper dosing and monitoring to achieve desired serum testosterone concentrations. Important safety information includes warnings about secondary exposure to testosterone, contraindications in men with carcinoma of the breast or known/suspected carcinoma of the prostate, and potential adverse reactions. Main dosing recommendations involve starting with 60 mg of testosterone applied once daily, with adjustments based on serum testosterone concentrations. Special population considerations include use during pregnancy, nursing, pediatric use, and geriatric use, with specific guidelines and precautions for each group.

Key Clinical Findings and Indications

  • Replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone
  • Primary hypogonadism (congenital or acquired)
  • Hypogonadotropic hypogonadism (congenital or acquired)

Important Safety Information

Warning

Secondary exposure to testosterone can occur, and patients should be advised to strictly adhere to recommended instructions for use.

Contraindications

  • Men with carcinoma of the breast or known/suspected carcinoma of the prostate
  • Pregnant or breastfeeding women

Adverse Reactions

  • Skin application site reactions
  • Increased hematocrit
  • Headache
  • Diarrhea
  • Vomiting
  • Increased serum PSA

Dosing Recommendations

General Guidance

Dose adjustments can be made based on serum testosterone concentrations, with decreases or increases in 30 mg increments.

Hypogonadism

Adult Dose

60 mg of testosterone applied once daily

Pediatric Dose

Not established for males <18 years old

Special Population Considerations

Pregnancy

  • Testosterone topical solution is contraindicated during pregnancy or in women who may become pregnant
  • Testosterone is teratogenic and may cause fetal harm

Nursing Mothers

  • Testosterone topical solution is contraindicated in nursing women
  • Testosterone may adversely affect lactation

Pediatric Use

  • Safety and efficacy not established in males <18 years old
  • Improper use may result in acceleration of bone age and premature closure of epiphyses

Geriatric Use

  • Insufficient numbers of geriatric patients in controlled clinical studies
  • Potential incremental risk of cardiovascular disease and prostate cancer